PRESS RELEASE published on 12/12/2024 at 21:30, 1 year 10 months ago Inside Information / Other news releases Medincell joins Euronext SBF 120 & CAC Mid 60 indices, enhancing visibility and investor appeal. Market capitalization-based indices by Euronext. Effective inclusion from Dec 20 Market Capitalization Medincell Index Inclusion Euronext SBF 120 CAC Mid 60
BRIEF published on 11/28/2024 at 18:45, 1 year 10 months ago Medincell Announces Video Conference for Half-Year Results Half-year Results Schizophrenia Medincell Videoconference BEPO Technology
BRIEF published on 11/22/2024 at 18:05, 1 year 10 months ago MedinCell: Update of share capital and voting rights Share Capital Voting Rights Euronext Actions Medincell
BRIEF published on 11/06/2024 at 13:47, 1 year 11 months ago Medincell: 2024 revenues on the rise and significant clinical progress Clinical Trial Revenue Projections Medincell Olanzapine LAI UZEDY
PRESS RELEASE published on 11/06/2024 at 13:42, 1 year 11 months ago Inside Information / Other news releases Medincell achieves 25% increase in 2024 UZEDY® revenue outlook reaching $100M and key milestone in Olanzapine LAI Phase 3 clinical trials. Teva Pharmaceuticals shares Q3 results Revenue Clinical Trials Medincell Teva Pharmaceuticals UZEDY
BRIEF published on 10/01/2024 at 15:47, 2 years ago Threshold crossing by Mirova in MEDINCELL Capital Actions Threshold Crossing Medincell Mirova
BRIEF published on 09/24/2024 at 11:54, 2 years ago Teva and Medincell Present Promising Results on Olanzapine LAI for Schizophrenia Clinical Trial Schizophrenia Medincell Teva Olanzapine LAI
PRESS RELEASE published on 09/24/2024 at 11:53, 2 years ago Inside Information / Other news releases Teva and Medincell reveal positive efficacy, safety, and tolerability data from Phase 3 study on Olanzapine LAI for schizophrenia treatment, presenting at ECNP 2024 Schizophrenia Treatment Phase 3 Study Medincell Teva Olanzapine LAI
BRIEF published on 09/18/2024 at 10:13, 2 years ago Mirova crosses the threshold of 5% of voting rights in MEDINCELL Voting Rights Actions Threshold Crossing Medincell Mirova
BRIEF published on 09/11/2024 at 07:35, 2 years 1 month ago Medincell establishes a new liquidity contract with Rothschild Martin Maurel Common Shares Euronext Paris Liquidity Contract Rothschild Martin Maurel Medincell
Published on 10/16/2026 at 05:55, 1 hour 38 minutes ago Collective Metals Announces Private Placement of Hard Dollar and Flow-Through Units
Published on 10/16/2026 at 02:10, 5 hours 23 minutes ago Nova Scotia Silver Explorer TruSilver Metals Corp. Anticipates TSXV Trading Under "TAG" on October 27
Published on 10/16/2026 at 01:45, 5 hours 48 minutes ago Faraday Copper Closes the Acquisition of the San Manuel Project in Arizona and Mobilizes Drill Rigs
Published on 10/16/2026 at 01:30, 6 hours 3 minutes ago LNG Energy Group Announces Closing of Second Tranche of Private Placement
Published on 10/15/2026 at 23:08, 8 hours 25 minutes ago ACCESS Newswire to Present at the 20th Annual LD Micro Main Event XX - Tuesday October 20, 2026 - 11:00AM PT (2:00PM ET)
Published on 10/16/2026 at 07:00, 33 minutes ago PolyPeptide Group: Definitive interim result of the public tender offer of Samsung Biologics Co., Ltd.
Published on 10/15/2026 at 22:30, 9 hours 3 minutes ago Porsche Mission S: the essence of the sports car reinterpreted
Published on 10/15/2026 at 20:30, 11 hours 3 minutes ago Nordex Group reports strong preliminary Q3/2026 results and raises EBITDA margin guidance for full year 2026
Published on 10/15/2026 at 20:28, 11 hours 4 minutes ago EQS-Adhoc: Nordex SE: Nordex Group reports strong preliminary Q3/2026 results and raises EBITDA margin guidance for full year 2026
Published on 10/15/2026 at 18:50, 12 hours 43 minutes ago September & first 9 months of 2026 traffic figures - Revision of Traffic assumptions for 2026
Published on 10/15/2026 at 17:45, 13 hours 48 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
